Oryzon Genomics S.A. announced a private placement that it will issue a total of 27,110,751 of the issued and outstanding common shares of the Corporation at an issue price of ?3.68 per share for the gross proceeds of up to ?100,000,000 on June 28, 2024. The transaction has been approved by its Annual General Meeting of Shareholders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.802 EUR | -0.66% |
|
-0.88% | -4.56% |
Jul. 08 | Oryzon Set to Secure Two Patents for Psychiatric Disorder Drug in Japan | MT |
Jun. 28 | Oryzon Genomics S.A. announced that it expects to receive ?99.767564 million in funding | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.56% | 113M | |
+17.09% | 45.34B | |
+42.10% | 40.42B | |
-9.70% | 37.92B | |
+33.28% | 31.75B | |
-8.98% | 27.71B | |
+13.37% | 26.52B | |
+44.11% | 13.96B | |
+32.33% | 12.44B | |
-7.26% | 11.26B |
- Stock Market
- Equities
- ORY Stock
- News Oryzon Genomics S.A.
- Oryzon Genomics S.A. announced that it expects to receive ?99.767564 million in funding